Clearside Biomedical, Inc. Files Registration Statement for Proposed Initial Public Offering

ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, a clinical-stage biopharmaceutical company developing drugs for the eye, announces filing of registration statement for proposed Initial Public Offering.

Source:: http://feeds.businesswire.com/click.phdo?i=ed80a643bd7ab0210bb40f833080d9d0

Print Friendly, PDF & Email

Share This

Share this post with your friends!